Andrew Gengos is CFO and Chief Business Officer at Athira Pharma, Inc. (ATHA). They have made 11 open-market trades across 3 companies since 2013, most recently 2026-01-14.
CIK 0001563623
8 open-market purchases totalling $347K since 2013, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | BUY | 2025-06-27 | 2025-06-30 | $3.93 | $20K | +25.6% | +51.5% | +99.7% |
| TERN | BUY | 2025-06-13 | 2025-06-16 | $3.81 | $57K | -8.8% | +25.5% | +69.8% |
| ATHA | SELL | 2024-09-05 | 2024-09-05 | $0.57 | $725 | -12.5% | -22.7% | +12.1% |
| ATHA | SELL | 2024-01-05 | 2024-02-16 | $2.91 | $4K | +4.6% | -32.3% | -26.4% |
| ATHA | BUY | 2023-06-07 | 2023-06-09 | $3.43 | $51K | -9.6% | -14.5% | -38.3% |
| ATHA | BUY | 2023-06-02 | 2023-06-06 | $2.94 | $162K | -10.6% | -16.4% | -29.4% |
| ATHA | SELL | 2023-01-05 | 2024-01-08 | $2.91 | $4K | -8.3% | -1.3% | -22.9% |
| IMUC | BUY | 2015-11-30 | 2015-12-02 | $0.44 | $4K | N/A | N/A | N/A |
| IMUC | BUY | 2015-02-18 | 2015-02-20 | $0.60 | $25K | N/A | N/A | N/A |
| IMUC | BUY | 2014-08-14 | 2014-08-14 | $0.90 | $9K | N/A | N/A | N/A |
| IMUC | BUY | 2013-12-18 | 2013-12-18 | $0.72 | $19K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.